OCGN - Ocugen, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
9,666
15,634
15,566
21,577
Selling General and Administrative
5,690
10,204
9,384
8,530
Total Operating Expenses
15,355
25,838
24,950
30,107
Operating Income or Loss
-15,355
-25,838
-24,950
-30,107
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-15,677
17,765
-1,598
17,059
Income Before Tax
-33,443
-8,643
-26,414
-16,208
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-33,443
-8,643
-26,414
-16,208
Net Income
-33,443
-8,643
-26,414
-16,208
Net Income available to common shareholders
-33,490
-8,522
-22,499
-13,863
Reported EPS
Basic
-
-13.80
-59.40
-58.20
Diluted
-
-47.40
-59.40
-130.80
Weighted average shares outstanding
Basic
-
607
378
238
Diluted
-
618
378
240
EBITDA
-
-25,388
-24,950
-30,107